NCT03390998

Brief Summary

This multi-site international clinical research project is a collaboration between investigators from multiple institutions in the USA, Canada, and Europe. Approximately 7 to 11 sites will participate and provide data for analysis. Clinical operations (for data collection and analysis) across sites will be managed by Stanford. The study purpose is to determine differences in clinical and imaging presentation, in-hospital management and prognosis in peripartum and non-peripartum SCAD patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
241

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Nov 2017

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 28, 2017

Completed
15 days until next milestone

First Submitted

Initial submission to the registry

December 13, 2017

Completed
23 days until next milestone

First Posted

Study publicly available on registry

January 5, 2018

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 31, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 31, 2019

Completed
Last Updated

September 25, 2019

Status Verified

September 1, 2019

Enrollment Period

1.5 years

First QC Date

December 13, 2017

Last Update Submit

September 23, 2019

Conditions

Keywords

Pregnancy-related SCADMyocardial Infarction

Outcome Measures

Primary Outcomes (1)

  • First Major Adverse Cardiovascular Event (post-SCAD)

    The time from the first SCAD event until the first occurrence of (1) myocardial infarction, (2) re-vascularization, (3) stroke, or (4) death due to cardiovascular cause.

    First SCAD event represents t=0. Time (in days) from t=0 until the first occurrence of any of the above, for up to 6-months after t=0.

Secondary Outcomes (4)

  • Depression

    At survey administration (post-SCAD), ranging from 6-months to 10 years post SCAD.

  • Anxiety

    At survey administration (post-SCAD), ranging from 6-months to 10 years post SCAD.

  • Stress

    At survey administration (post-SCAD), ranging from 6-months to 10 years post SCAD.

  • Post-Traumatic Stress Disorder

    At survey administration (post-SCAD), ranging from 6-months to 10 years post SCAD.

Study Arms (2)

Peripartum SCAD

Female patients who experienced any SCAD event that occurred during pregnancy or up to 1 year post-delivery

Non-peripartum SCAD

Female patients who experienced any SCAD with event onset outside of the pregnancy period

Eligibility Criteria

Age18 Years+
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsOnly women will be studied as the primary question relates to pregnancy-related SCAD
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Participants with pregnancy-related and non pregnancy-related SCAD will be recruited from the population of SCAD patients known to an international collaborative of investigators. We expect to enroll approximately 400 patients, 100 of whom have experienced peripartum SCAD. For each enrolled participant with peripartum SCAD, we will enroll 3 patients with non-peripartum SCAD who are the closest match on age at SCAD event and country.

You may qualify if:

  • Sites contacting patients and/or conducting the survey
  • Female adults 18 years of age and older
  • Voluntary participation
  • Patients with a known or suspected diagnosis of SCAD
  • Ability to read in English
  • Ability to access online consent and questionnaire portal
  • Sites not contacting patients and/or conducting the survey
  • Female adults 18 years of age and older
  • Patients with a known or suspected diagnosis of SCAD

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Stanford University Medical Center

Palo Alto, California, 94305, United States

Location

MeSH Terms

Conditions

Coronary Artery Dissection, SpontaneousMyocardial Infarction

Condition Hierarchy (Ancestors)

Myocardial IschemiaHeart DiseasesCardiovascular DiseasesVascular DiseasesInfarctionIschemiaPathologic ProcessesPathological Conditions, Signs and SymptomsNecrosis

Study Officials

  • Jennifer Ann Tremmel, MD, MS

    Stanford University

    PRINCIPAL INVESTIGATOR
  • Katharine S. Edwards, PhD

    Stanford University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Clinical Assistant Professor, Medicine - Cardiovascular Medicine

Study Record Dates

First Submitted

December 13, 2017

First Posted

January 5, 2018

Study Start

November 28, 2017

Primary Completion

May 31, 2019

Study Completion

May 31, 2019

Last Updated

September 25, 2019

Record last verified: 2019-09

Locations